WILLIAM D YOUNG Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WILLIAM D YOUNG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of WILLIAM D YOUNG. WILLIAM D YOUNG is Director in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and CEO and Chairman of the Board in Monogram Biosciences, Inc. ($VLGC) and Chairman and CEO in Monogram Biosciences, Inc. ($VLGC) and Chairman, CEO in Monogram Biosciences, Inc. ($VLGC) and Director in Theravance Biopharma, Inc. ($TBPH).
Latest Insider Trading Transactions of WILLIAM D YOUNG
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BMRN, VLGC, TBPH, VRTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 2021 | TBPH | Theravance Biophar ... | YOUNG WILLIAM D | Director | Option Exercise | A | 20.35 | 6,000 | 122,100 | 6,000 | |
| Apr 29 2021 | TBPH | Theravance Biophar ... | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 9,828 | 0 | 68,158 | 58.3 K to 68.2 K (+16.85 %) |
| Jun 03 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Option Exercise | A | 286.27 | 4,527 | 1,295,944 | 4,527 | |
| Apr 30 2020 | TBPH | Theravance Biophar ... | YOUNG WILLIAM D | Director | Option Exercise | A | 30.14 | 6,000 | 180,840 | 6,000 | |
| Apr 30 2020 | TBPH | Theravance Biophar ... | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 6,635 | 0 | 58,330 | 51.7 K to 58.3 K (+12.83 %) |
| Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Option Exercise | M | 72.14 | 20,000 | 1,442,800 | 0 | |
| Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Sell | S | 220.08 | 100 | 22,008 | 9,311 | 9.4 K to 9.3 K (-1.06 %) |
| Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Sell | S | 219.37 | 10,134 | 2,223,096 | 9,411 | 19.5 K to 9.4 K (-51.85 %) |
| Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Sell | S | 218.73 | 7,266 | 1,589,292 | 19,545 | 26.8 K to 19.5 K (-27.10 %) |
| Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Sell | S | 217.72 | 2,500 | 544,300 | 26,811 | 29.3 K to 26.8 K (-8.53 %) |
| Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Buy | M | 72.14 | 20,000 | 1,442,800 | 29,311 | 9.3 K to 29.3 K (+214.80 %) |
| Jan 02 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Option Exercise | M | 65.65 | 30,000 | 1,969,500 | 0 | |
| Jan 02 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Sell | S | 221.16 | 300 | 66,348 | 9,311 | 9.6 K to 9.3 K (-3.12 %) |
| Jan 02 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Sell | S | 220.25 | 500 | 110,125 | 9,611 | 10.1 K to 9.6 K (-4.95 %) |
| Jan 02 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Sell | S | 218.93 | 21,798 | 4,772,236 | 10,111 | 31.9 K to 10.1 K (-68.31 %) |
| Jan 02 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Sell | S | 218.05 | 7,402 | 1,614,006 | 31,909 | 39.3 K to 31.9 K (-18.83 %) |
| Jan 02 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Buy | M | 65.65 | 30,000 | 1,969,500 | 39,311 | 9.3 K to 39.3 K (+322.20 %) |
| May 02 2019 | TBPH | Theravance Biophar ... | YOUNG WILLIAM D | Director | Option Exercise | A | 23.85 | 6,000 | 143,100 | 6,000 | |
| May 02 2019 | TBPH | Theravance Biophar ... | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 8,385 | 0 | 51,695 | 43.3 K to 51.7 K (+19.36 %) |
| Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Option Exercise | A | 152.74 | 3,229 | 493,197 | 3,229 | |
| Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 1,801 | 0 | 6,930 | 5.1 K to 6.9 K (+35.11 %) |
| May 03 2018 | TBPH | Theravance Biophar ... | YOUNG WILLIAM D | Director | Option Exercise | A | 24.43 | 6,000 | 146,580 | 6,000 | |
| May 03 2018 | TBPH | Theravance Biophar ... | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 8,186 | 0 | 43,310 | 35.1 K to 43.3 K (+23.31 %) |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Option Exercise | M | 125.71 | 5,295 | 665,634 | 5,295 | |
| Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 2,188 | 0 | 5,129 | 2.9 K to 5.1 K (+74.40 %) |
| May 18 2017 | TBPH | Theravance Biophar ... | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 6,000 | 0 | 35,124 | 29.1 K to 35.1 K (+20.60 %) |
| Jun 03 2016 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Option Exercise | A | 93.51 | 7,073 | 661,396 | 7,073 | |
| Jun 03 2016 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Grant | A | 0.01 | 2,941 | 29 | 2,941 | 0 to 2.9 K |
| May 05 2016 | TBPH | Theravance Biophar ... | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 6,000 | 0 | 29,124 | 23.1 K to 29.1 K (+25.95 %) |
| Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | YOUNG WILLIAM D | Director | Option Exercise | A | 122.27 | 3,300 | 403,491 | 3,300 | |
| Jun 18 2015 | BMRN | BIOMARIN PHARMACEU ... | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 1,100 | 0 | 11,875 | 10.8 K to 11.9 K (+10.21 %) |
| Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Option Exercise | A | 127.54 | 20,000 | 2,550,800 | 20,000 | |
| Apr 24 2015 | TBPH | Theravance Biophar ... | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 6,000 | 0 | 23,124 | 17.1 K to 23.1 K (+35.04 %) |
| Aug 09 2005 | VLGC | Monogram Bioscienc ... | YOUNG WILLIAM D | Chairman, CEO | Buy | P | 2.37 | 2,500 | 5,921 | 227,561 | 225.1 K to 227.6 K (+1.11 %) |
| Aug 09 2005 | VLGC | Monogram Bioscienc ... | YOUNG WILLIAM D | Chairman, CEO | Buy | P | 2.37 | 5,000 | 11,835 | 225,061 | 220.1 K to 225.1 K (+2.27 %) |
| Aug 09 2005 | VLGC | Monogram Bioscienc ... | YOUNG WILLIAM D | Chairman, CEO | Buy | P | 2.37 | 5,000 | 11,828 | 220,061 | 215.1 K to 220.1 K (+2.32 %) |
| Aug 09 2005 | VLGC | Monogram Bioscienc ... | YOUNG WILLIAM D | Chairman, CEO | Buy | P | 2.36 | 5,000 | 11,800 | 215,061 | 210.1 K to 215.1 K (+2.38 %) |
| Aug 09 2005 | VLGC | Monogram Bioscienc ... | YOUNG WILLIAM D | Chairman, CEO | Buy | P | 2.37 | 7,500 | 17,775 | 210,061 | 202.6 K to 210.1 K (+3.70 %) |
| Mar 04 2005 | VLGC | Monogram Bioscienc ... | YOUNG WILLIAM D | Chairman and CEO | Option Exercise | A | 2.28 | 1,650,000 | 3,762,000 | 1,650,000 | |
| Mar 25 2004 | VLGC | Monogram Bioscienc ... | YOUNG WILLIAM D | CEO and Chairman of ... | Option Exercise | A | 1.51 | 300,000 | 453,000 | 300,000 | |
| Mar 25 2004 | VLGC | Monogram Bioscienc ... | YOUNG WILLIAM D | CEO and Chairman of ... | Option Exercise | A | 1.51 | 300,000 | 453,000 | 300,000 | |
| Mar 19 2004 | VLGC | Monogram Bioscienc ... | YOUNG WILLIAM D | CEO and Chairman of ... | Option Exercise | A | 3.00 | 300,000 | 900,000 | 300,000 |
Page: 1